Scratch Wound-Healing Assay for Quantifying Directional 2D Migration of Serum-Starved NIH/3T3 Fibroblasts Under Mitomycin C Proliferation Block

Factorial design with treatment (vehicle, 1, 10, 50 µM Y-27632) as the independent variable and percent wound closure at 0, 6, 12, and 24 h as the dependent variable. Each condition is run in n = 3 wells (technical replicates) across N = 3 independent biological replicates on separate passages (P12-P18). Two non-overlapping fields per scratch are imaged at fixed reference marks scribed on the plate underside; field selection is randomized within the scratch. Image analysis is performed blinded by relabeling files with a random code. Mitomycin C (10 µg/mL, 2 h) is applied to all wells before scratching to equalize proliferation across conditions.

BSL-1 for NIH/3T3. Mitomycin C is a potent mutagen/carcinogen — handle in a biosafety cabinet with double nitrile gloves, dedicated waste, and inactivate liquid waste per institutional SOP (do not pour down the drain). DMSO is a skin-penetration enhancer; avoid co-handling with toxic compounds. Wear lab coat, gloves, and eye protection. Decontaminate work surfaces with 70% ethanol; autoclave or bleach (10%) biological waste.

Vehicle control: DMSO at the highest carrier concentration used (<0.1%) confirms the solvent does not affect migration. Positive migration control: untreated serum-starved wells (0.5% FBS, no inhibitor) define maximal closure rate. Proliferation control: a parallel set WITHOUT mitomycin C to confirm the block is suppressing division (compared via end-point nuclei counts). No-scratch confluent control verifies the monolayer remains intact and confluent (no spontaneous gaps). Live/dead staining at end-point controls for compound cytotoxicity masquerading as reduced migration.

Vehicle wells should show progressive closure reaching roughly 70-90% by 24 h with an approximately linear early-phase rate of ~15-25 µm/h for NIH/3T3. Y-27632 is expected to reduce 24 h closure in a concentration-dependent manner (e.g., ~50-70% at 10 µM, <40% at 50 µM), with EthD-1-positive (dead) cells remaining <5% across all conditions, confirming the effect is on migration, not viability. Initial gap widths should be 400-700 µm and consistent (CV < 15%) across wells.

• NIH/3T3 fibroblasts (ATCC CRL-1658), used between passage 12-18
• DMEM, high glucose, with GlutaMAX, sterile-filtered
• Fetal bovine serum (FBS), heat-inactivated, used at 10% (growth) and 0.5% (starvation/migration)
• Penicillin-streptomycin (100 U/mL / 100 µg/mL final)
• Mitomycin C, 10 µg/mL working in serum-free DMEM (from 0.5 mg/mL stock in sterile water, light-protected)
• Y-27632 dihydrochloride, 10 mM stock in sterile water; working 1/10/50 µM
• Dimethyl sulfoxide (DMSO), vehicle, matched to highest carrier volume (<0.1% final)
• Dulbecco's PBS, Ca/Mg-free, sterile
• 0.25% Trypsin-EDTA
• 24-well flat-bottom tissue-culture-treated plates
• Sterile P200 pipette tips (for scratching)
• Calcein-AM (2 µM) and ethidium homodimer-1 (4 µM) for end-point viability

To quantify the rate of collective 2D migration of NIH/3T3 fibroblasts into a reproducible cell-free gap created by a pipette-tip scratch on a confluent monolayer, while pharmacologically blocking proliferation with mitomycin C so that the measured gap closure reflects migration rather than cell division. The assay establishes a baseline migration rate and a concentration-response relationship for a test compound (Y-27632 ROCK inhibitor) on percent wound closure over 24 h.

1. Seed NIH/3T3 at 1.2 x 10^5 cells/well in 0.5 mL DMEM/10% FBS in 24-well plates; incubate 24 h at 37 C, 5% CO2 to reach >95% confluence.
2. Replace medium with DMEM/0.5% FBS and serum-starve 6 h to lower baseline proliferation and synchronize.
3. Add mitomycin C to 10 µg/mL in serum-free DMEM; incubate 2 h at 37 C. Wash 2x with 0.5 mL PBS.
4. Using a fresh sterile P200 tip held vertical, scratch a single straight line across each well in one smooth pass. Wash 2x with PBS to remove detached cells.
5. Add 0.5 mL DMEM/0.5% FBS containing vehicle or Y-27632 (1/10/50 µM). Record this as t = 0.
6. Image each well at marked reference fields on a phase-contrast microscope (10x) at t = 0, 6, 12, and 24 h; keep the plate on a 37 C stage or return promptly to the incubator between time points.
7. At 24 h, perform live/dead staining (calcein-AM 2 µM / EthD-1 4 µM, 20 min) and image to confirm viability.
8. Export images as 8-bit TIFFs for blinded analysis.

Independent variable: Y-27632 concentration (0, 1, 10, 50 µM). Dependent variable: percent wound closure = (gap area at t0 - gap area at t) / gap area at t0 x 100, and the derived linear migration rate (µm/h). Controlled variables: cell passage number, seeding density, confluence at scratch, scratch width and orientation, serum concentration (0.5%), mitomycin C dose/time, imaging fields/magnification, incubation temperature and CO2, time points.

If gap closure in the scratch assay is driven primarily by Rho/ROCK-dependent actomyosin contractility and lamellipodial protrusion, then ROCK inhibition with Y-27632 will reduce the rate of directional migration and slow percent wound closure relative to vehicle (DMSO) controls in a concentration-dependent manner, without altering monolayer viability over the 24 h window.

Gap area at each time point is measured in Fiji/ImageJ using the MRI Wound Healing Tool or manual freehand selection over the cell-free region (variance-filter + threshold to define the leading edges); two fields per scratch are averaged. Percent closure is normalized to the matched t = 0 gap for each well to remove initial-width variability. Migration rate is the slope of gap-edge displacement vs time during the linear phase (0-12 h). Viability is the fraction of calcein-positive cells. All file names are coded before measurement to blind the analyst.

Ragged or wide variable scratches: use a single confident pass with a fresh tip held perpendicular; consider a culture-insert (e.g., 2-well insert) for uniform 500 µm gaps. Cells detaching as sheets after scratch: monolayer was over-confluent or trypsin-stressed; reduce seeding or confluence time. Closure faster than expected / proliferation not blocked: verify mitomycin C activity and that the 2 h incubation occurred; add parallel no-mitomycin nuclei counts. High cell death across all wells: mitomycin C dose too high or starvation too long — drop to 6 h starvation. Poor edge detection in software: improve contrast/illumination evenness and image at fixed marked fields each time.

Percent closure at 24 h is compared across concentrations by one-way ANOVA on the per-biological-replicate means (N = 3), with Dunnett's post-hoc test versus vehicle (alpha = 0.05). Concentration-response is fit to a four-parameter logistic to estimate IC50 of closure inhibition. Time-course curves are compared by two-way repeated-measures ANOVA (time x treatment) with Sidak correction. A power analysis (alpha 0.05, power 0.8) indicates N = 3 biological replicates detect a 20% absolute difference in closure given typical SD ~7%.